EVMN financials
Evommune (EVMN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
EVMN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $13.00M | – | -$81.07M | -$68.87M | -11.22 |
| 2024 | $7.00M | – | -$70.01M | -$68.31M | -45.29 |
- EVMN revenue was $13.00M in fiscal 2025, net income -$68.87M.
Updated 2026-11-12 02:51 UTC